| Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate N Murphy, M Diviney, J Szer, P Bardy, A Grigg, R Hoyt, B King, ... Bone marrow transplantation 37 (8), 773-779, 2006 | 41 | 2006 |
| An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case–control study GS Dite, NM Murphy, R Allman PLoS One 16 (2), e0247205, 2021 | 40 | 2021 |
| Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 GS Dite, NM Murphy, R Allman Epidemiology & Infection 149, e162, 2021 | 30 | 2021 |
| Genome sequencing of human in vitro fertilisation embryos for pathogenic variation screening NM Murphy, TS Samarasekera, L Macaskill, J Mullen, LJF Rombauts Scientific reports 10 (1), 3795, 2020 | 23 | 2020 |
| Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals JJR Masson, CL Cherry, NM Murphy, I Sada-Ovalle, T Hussain, ... Frontiers in Immunology 9, 900, 2018 | 16 | 2018 |
| Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence G Bobashev, S Mars, N Murphy, C Dreisbach, W Zule, D Ciccarone PLoS One 14 (12), e0215042, 2019 | 13 | 2019 |
| Polygenic risk scores for cardiovascular diseases and type 2 diabetes CK Wong, E Makalic, GS Dite, L Whiting, NM Murphy, JL Hopper, ... Plos one 17 (12), e0278764, 2022 | 12 | 2022 |
| The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants NM Murphy, M Diviney, J Szer, P Bardy, A Grigg, R Hoyt, ... Biology of Blood and Marrow Transplantation 18 (5), 722-730, 2012 | 12 | 2012 |
| Haplotyping the human leukocyte antigen system from single chromosomes NM Murphy, M Burton, DR Powell, FJ Rossello, D Cooper, A Chopra, ... Scientific Reports 6 (1), 30381, 2016 | 7 | 2016 |
| Human leukocyte antigen haplotype phasing by allele‐specific enrichment with peptide nucleic acid probes NM Murphy, CW Pouton, HR Irving Molecular Genetics & Genomic Medicine 2 (3), 245-253, 2014 | 5 | 2014 |
| Melanoma risk prediction based on a polygenic risk score and clinical risk factors CK Wong, GS Dite, E Spaeth, NM Murphy, R Allman Melanoma Research 33 (4), 293-299, 2023 | 4 | 2023 |
| Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk GS Dite, E Spaeth, NM Murphy, R Allman The Prostate 83 (10), 962-969, 2023 | 2 | 2023 |
| Predicting 10-Year Risk of Pancreatic Cancer Using a Combined Genetic and Clinical Model GS Dite, E Spaeth, CK Wong, NM Murphy, R Allman Gastro Hep Advances 2 (7), 979-989, 2023 | 1 | 2023 |
| Methods of assessing risk of developing a severe response to coronavirus infection GS Dite, NM Murphy, R Allman US Patent App. 17/667,282, 2022 | 1 | 2022 |
| Genetic associations with severe COVID-19 NM Murphy, GS Dite, R Allman medRxiv, 2021.03. 29.21254509, 2021 | 1 | 2021 |
| An integrated clinical and genetic model for predicting risk of severe COVID-19 GS Dite, NM Murphy, R Allman medRxiv, 2020.09. 30.20204453, 2020 | 1 | 2020 |
| High Molecular Weight DNA Enrichment with Peptide Nucleic Acid Probes NM Murphy, CW Pouton, HR Irving Haplotyping: Methods and Protocols, 73-85, 2017 | 1 | 2017 |
| Computer System and Method for Coordinating Process of Creating and Managing a Punch Item M Weeks, N Murphy, S Kang, A Kaur US Patent App. 18/492,741, 2024 | | 2024 |
| Computer system and method for coordinating process of creating and managing a punch item M Weeks, N Murphy, S Kang, A Kaur US Patent 11,797,900, 2023 | | 2023 |
| Computer System and Method for Predicting Risk Level of Punch Items C Torres, N Kaufman, E Sellin, W Peliks, M Weeks, A Kaur, N Murphy, ... US Patent App. 18/158,278, 2023 | | 2023 |
James McCluskeyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity在 unimelb.edu.au 的电子邮件经过验证
